Analyst Ratings for X4 Pharmaceuticals (XFOR)
XFOR Rating Summary
XFOR Price Target Summary
- Highest: $12.00 (Guggenheim)
- Lowest: $5.00 (H.C. Wainwright)
- Average: $10.00
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$10.00 (+161.8%)
* Over Last 12-Mos
Rating Score: 9.3 / 10
Percentile Rank: 90%
Avg. $ Target:
$10.00 (+161.8%)
* Over Last 12-Mos
Rating Score: 9.3 / 10
Percentile Rank: 90%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 7/10/2026 | Wells Fargo | Derek Archila | New Coverage | Overweight (N/A) |
11.00 (N/A) |
3.96 (3.82) |
-3.54% | Details |
| 6/2/2026 | Leerink | N/A | New Coverage | Outperform (N/A) |
12.00 (N/A) |
4.11 (3.82) |
-7.06% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
